Statistics for Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation
Total visits
views | |
---|---|
Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation | 15 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 2 |
March 2024 | 3 |
April 2024 | 2 |
May 2024 | 1 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
Shueb_umn_0130E_23594.pdf(legacy) | 18 |
Shueb_umn_0130E_23594.pdf | 12 |
Top country views
views | |
---|---|
United States | 6 |
United Kingdom | 4 |
Taiwan | 2 |
Switzerland | 1 |
China | 1 |
Germany | 1 |
Hong Kong SAR China | 1 |
Indonesia | 1 |
Ireland | 1 |
India | 1 |
Japan | 1 |
Russia | 1 |
Turkey | 1 |
Ukraine | 1 |
Top city views
views | |
---|---|
Chicago | 2 |
Ankara | 1 |
Ashburn | 1 |
Camberley | 1 |
Central | 1 |
Daettlikon | 1 |
Dublin | 1 |
Ipswich | 1 |
Jakarta | 1 |
London | 1 |
Ludhiana | 1 |
Minneapolis | 1 |
Rothenbach an der Pegnitz | 1 |
Taichung | 1 |
Valley Stream | 1 |
Vladivostok | 1 |